Acetylcholinesterase loosens the brain's cholinergic anti-inflammatory response and promotes epileptogenesis

Frontiers in Molecular Neuroscience

Volumn , Issue MAY 2012, 2012, Pages

  Gnatek, Yehudit ^a,c   Zimmerman, Gabriel ^b   Goll, Yael ^b   Najami, Naim ^a,d   Soreq, Hermona ^b   Friedman, Alon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Acetylcholinesterase; Epileptogenesis; Hippocampus; Inflammation; Status epilepticus

Indexed keywords

ACETYLCHOLINESTERASE;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CELL ACTIVATION; CHOLINERGIC STIMULATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; ENTORHINAL CORTEX; EPILEPTOGENESIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPUS; IMMUNE RESPONSE; INNATE IMMUNITY; MICROGLIA; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SUBICULUM; UPREGULATION;

EID: 84864003871     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2012.00066     Document Type: Article

References (61)

1. Abraham, E., Arcaroli, J., Carmody, A., Wang, H., and Tracey, K. J. (2000). HMG-1 as a mediator of acute lunginflammation. J. Immunol. 165, 2950-2954.
2. Amor, S., Puentes, F., Baker, D., and van der Valk, P. (2010). Inflammation in neurodegenerative diseases. Immunology 129, 154-169.
3. Beeri, R., Andres, C., Lev-Lehman, E., Timberg, R., Huberman, T., Shani, M., and Soreq, H. (1995). Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5, 1063-1071.
4. Berson, A., Knobloch, M., Hanan, M., Diamant, S., Sharoni, M., Schuppli, D., Geyer, B. C., Ravid, R., Mor, T. S., Nitsch, R. M., and Soreq, H. (2008). Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. Brain 131, 109-119.
5. Bond, C. E., Patel, P., Crouch, L., Tetlow, N., Day, T., Abu-Hayyeh, S., Williamson, C., and Greenfield, S. A. (2006). Astroglia up-regulate transcription and secretion of 'readthrough' acetylcholinesterase following oxidative stress. Eur. J. Neurosci. 24, 381-386.
6. Bon, S., Toutant, J. P., Meflah, K., and Massoulie, J. (1988). Amphiphilic and nonamphiphilic forms of Torpedo cholinesterases: I. Solubility and aggregation properties. J. Neurochem. 51, 776-785.
7. Borges, K., Gearing, M., McDermott, D. L., Smith, A. B., Almonte, A. G., Wainer, B. H., and Dingledine, R. (2003). Neuronal and glial pathological changes during epileptogen-esis in the mouse pilocarpine model. Exp. Neurol. 182, 21-34.
8. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
9. Cavalheiro, E. A., Santos, N. F., and Priel, M. R. (1996). The pilocarpine model of epilepsy in mice. Epilepsia 37, 1015-1019.
10. Chen, J., Larionov, S., Pitsch, J., Hoerold, N., Ullmann, C., Elger, C. E., Schramm, J., and Becker, A. J. (2005). Expression analysis of metabotropic glutamate receptors I and III in mouse strains with different susceptibility to experimental temporal lobe epilepsy. Neurosci. Lett. 375, 192-197.
11. David, Y., Cacheaux, L. P., Ivens, S., Lapilover, E., Heinemann, U., Kaufer, D., and Friedman, A. (2009). Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? J. Neurosci. 29, 10588-10599.
12. De Araujo Furtado, M., Lumley, L. A., Robison, C., Tong, L. C., Lichtenstein, S., and Yourick, D. L. (2010). Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats. Epilepsia 51, 1503-1510.
13. Dhote, F., Carpentier, P., Barbier, L., Peinnequin, A., Baille, V., Pernot, F., Testylier, G., Beaup, C., Foquin, A., and Dorandeu, F. (2012). Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice. Toxicol. Appl. Pharmacol. 259, 195-209.
14. Dhote, F., Peinnequin, A., Carpentier, P., Baille, V., Delacour, C., Foquin, A., Lallement, G., and Dorandeu, F. (2007). Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 238, 166-176.
15. Fabene, P. F., Navarro, M. G., Martinello, M., Rossi, B., Merigo, F., Ottoboni, L., Bach, S., Angiari, S., Benati, D., Chakir, A., Zanetti, L., Schio, F., Osculati, A., Marzola, P., Nicolato, E., Homeister, J. W., Xia, L., Lowe, J. B., McEver, R. P., Osculati, F., Sbarbati, A., Butcher, E. C., and Constantin, G. (2008). A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 14, 1377-1383.
16. Friedman, A., and Dingledine, R. (2011). Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 52 (Suppl. 3), 33-39.
17. Friedman, A., Kaufer, D., and Heinemann, U. (2009). Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res. 85, 142-149.
18. Hayakawa, K., Mishima, K., Nozako, M., Hazekawa, M., Mishima, S., Fujioka, M., Orito, K., Egashira, N., Iwasaki, K., and Fujiwara, M. (2008). Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke 39, 951-958.
19. Ivens, S., Kaufer, D., Flores, L. P., Bechmann, I., Zumsteg, D., Tomkins, O., Seiffert, E., Heinemann, U., and Friedman, A. (2007). TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130, 535-547.
20. Karnovsky, M. J., and Roots, L. (1964). A "direct-coloring" thiocholine method for cholinesterases. J. His-tochem. Cytochem. 12, 219-221.
21. Kaufer, D., Friedman, A., Seidman, S., and Soreq, H. (1998). Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393, 373-377.
22. Kim, J. B., Sig, C. J., Yu, Y. M., Nam, K., Piao, C. S., Kim, S. W., Lee, M. H., Han, P. L., Park, J. S., and Lee, J. K. (2006). HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 26, 6413-6421.
23. Lotze, M. T., and Tracey, K. J. (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331-342.
24. Lucas, S. M., Rothwell, N. J., and Gibson, R. M. (2006). The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (Suppl. 1), S232-S240.
25. Marchi, N., Angelov, L., Masaryk, T., Fazio, V., Granata, T., Hernandez, N., Hallene, K., Diglaw, T., Franic, L., Najm, I., and Janigro, D. (2007). Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48, 732-742.
26. Marchi, N., Fan, Q., Ghosh, C., Fazio, V., Bertolini, F., Betto, G., Batra, A., Carlton, E., Najm, I., Granata, T., and Janigro, D. (2009). Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol. Dis. 33, 171-181.
27. Maroso, M., Balosso, S., Ravizza, T., Liu, J., Aronica, E., Iyer, A. M., Rossetti, C., Molteni, M., Casalgrandi, M., Manfredi, A. A., Bianchi, M. E., and Vezzani, A. (2010). Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 16, 413-419.
28. Meshorer, E., Biton, I. E., Ben-Shaul, Y., Ben-Ari, S., Assaf, Y., Soreq, H., and Cohen, Y. (2005a). Chronic cholinergic imbalances promote brain diffusion and transport abnormalities. FASEBJ. 19, 910-922.
29. Meshorer, E., Bryk, B., Toiber, D., Cohen, J., Podoly, E., Dori, A., and Soreq, H. (2005b). SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA. Mol. Psychiatry 10, 985-997.
30. Meshorer, E., Erb, C., Gazit, R., Pavlovsky, L., Kaufer, D., Friedman, A., Glick, D., Ben Arie, N., and Soreq, H. (2002). Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295, 508-512.
31. Meshorer, E., and Soreq, H. (2006). Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 29, 216-224.
32. Meshorer, E., Toiber, D., Zurel, D., Sahly, I., Dori, A., Cagnano, E., Schreiber, L., Grisaru, D., Tronche, F., and Soreq, H. (2004). Combinatorial complexity of 5' alternative acetylcholinesterase transcripts and protein products. J. Biol. Chem. 279, 29740-29751.
33. Nizri, E., Irony-Tur-Sinai, M., Faranesh, N., Lavon, I., Lavi, E., Weinstock, M., and Brenner, T. (2008). Suppression of neuroinflammation and immunomodu-lation by the acetylcholinesterase inhibitor rivastigmine. J. Neuro-immunol. 203, 12-22.
34. Pavlov, V. A., Ochani, M., Gallowitsch-Puerta, M., Ochani, K., Huston, J. M., Czura, C. J., Al-Abed, Y., and Tracey, K. J. (2006). Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl. Acad. Sci. U.S.A. 103, 5219-5223.
35. Pavlov, V. A., Parrish, W. R., Rosas-Ballina, M., Ochani, M., Puerta, M., Ochani, K., Chavan, S., Al-Abed, Y., and Tracey, K. J. (2009). Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 23, 41-45.
36. Pernot, F., Carpentier, P., Baille, V., Testylier, G., Beaup, C., Foquin, A., Filliat, P., Liscia, P., Coutan, M., Pierard, C., Beracochea, D., and Dorandeu, F. (2009). Intrahippocampal cholinesterase inhibition induces epileptogenesis in mice without evidence of neu-rodegenerative events. Neuroscience 162, 1351-1365.
37. Pitkanen, A., Kharatishvili, I., Karhunen, H., Lukasiuk, K., Immonen, R., Nairismägi, J., Gröhn, O., and Nissinen, J. (2007). Epileptogenesis in experimental models. Epilepsia 48, 13-20.
38. Racine, R. J. (1972). Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294.
39. Rappold, P. M., Lynd-Balta, E., and Joseph, S. A. (2006). P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Res. 1089, 171-178.
40. Rijkers, K., Majoie, H. J., Hoogland, G., Kenis, G., De, B. M., and Vles, J. S. (2009). The role of interleukin-1 in seizures and epilepsy: a critical review. Exp. Neurol. 216, 258-271.
41. Shibley, H., and Smith, B. N. (2002). Pilocarpine-induced status epilepti-cus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice. Epilepsy Res. 49, 109-120.
42. Shohami, E., Kaufer, D., Chen, Y., Seidman, S., Cohen, O., Ginzberg, D., Melamed-Book, N., Yirmiya, R., and Soreq, H. (2000). Antisense prevention of neuronal damages following head injury in mice. J. Mol. Med. 78, 228-236.
43. Shytle, R. D., Mori, T., Townsend, K., Vendrame, M., Sun, N., Zeng, J., Ehrhart, J., Silver, A. A., Sanberg, P. R., and Tan, J. (2004). Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 89, 337-343.
44. Sternfeld, M., Shoham, S., Klein, O., Flores-Flores, C., Evron, T., Idelson, G. H., Kitsberg, D., Patrick, J. W., and Soreq, H. (2000). Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. U.S.A. 97, 8647-8652.
45. Thullbery, M. D., Cox, H. D., Schule, T., Thompson, C. M., and George, K. M. (2005). Differential localization of acetylcholinesterase in neuronal and non-neuronal cells. J. Cell. Biochem. 96, 599-610.
46. Tracey, K. J. (2002). The inflammatory reflex. Nature 420, 853-859.
47. Tracey, K. J. (2007). Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117, 289-296.
48. Tracey, K. J. (2009). Reflex control of immunity. Nat. Rev. Immunol. 9, 418-428.
49. Turrin, N. P., and Rivest, S. (2004). Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol. Dis. 16, 321-334.
50. van Vliet, E. A., da Costa, A. S., Redeker, S., van Schaik, R., Aronica, E., and Gorter, J. A. (2007). Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130, 521-534.
51. Vezzani, A., Balosso, S., and Ravizza, T. (2008). The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 22, 797-803.
52. Vezzani, A., Conti, M., De, L. A., Ravizza, T., Moneta, D., Marchesi, F., and De Simoni, M. G. (1999). Interleukin-1beta immunoreactiv-ity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19, 5054-5065.
53. Vezzani, A., French, J., Bartfai, T., and Baram, T. Z. (2011). The role of inflammation in epilepsy. Nat. Rev. Neurol. 7, 31-40.
54. Vezzani, A., and Granata, T. (2005). Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia46, 1724-1743.
55. von Bernhardi, R., Ramirez, G., De Ferrari, G. V., and Inestrosa, N. C. (2003). Acetylcholinesterase induces the expression of the beta-amyloid precursor protein in glia and activates glial cells in culture. Neurobiol. Dis. 14, 447-457.
56. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K. R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P. E., Abumrad, N. N., Sama, A., and Tracey, K. J. (1999). HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251.
57. Wang, J., Zhang, H. Y., and Tang, X. C. (2010). Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J. Neurosci. Res. 88, 807-815.
58. Wang, Z. F., Wang, J., Zhang, H. Y., and Tang, X. C. (2008). Huperzine A exhibits anti-inflammatory and neu-roprotective effects in a rat model of transient focal cerebral ischemia. J. Neurochem. 106, 1594-1603.
59. Weissberg, I., Reichert, A., Heinemann, U., and Friedman, A. (2011). Blood-brain barrier dysfunction in epileptogenesis of the temporal lobe. Epilepsy Res. Treat. doi: 10.1155/2011/143908
60. Zhang, J., Takahashi, H. K., Liu, K., Wake, H., Liu, R., Maruo, T., Date, I., Yoshino, T., Ohtsuka, A., Mori, S., and Nishibori, M. (2011). Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42, 1420-1428.
61. Zimmerman, G., Njunting, M., Ivens, S., Tolner, E., Behrens, C. J., Gross, M., Soreq, H., Heinemann, U., and Friedman, A. (2008). Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. Eur. J. Neurosci. 27, 965-975.